IL32904A - Steroidal triethylammonium sulfates of the estrane series and methods of preparing same - Google Patents
Steroidal triethylammonium sulfates of the estrane series and methods of preparing sameInfo
- Publication number
- IL32904A IL32904A IL32904A IL3290469A IL32904A IL 32904 A IL32904 A IL 32904A IL 32904 A IL32904 A IL 32904A IL 3290469 A IL3290469 A IL 3290469A IL 32904 A IL32904 A IL 32904A
- Authority
- IL
- Israel
- Prior art keywords
- triethylammonium salt
- salt
- steroidal
- triethylammonium
- sulfate
- Prior art date
Links
- NKNFUMKGJYKPCT-UHFFFAOYSA-N n,n-diethylethanamine;sulfuric acid Chemical class [O-]S([O-])(=O)=O.CC[NH+](CC)CC.CC[NH+](CC)CC NKNFUMKGJYKPCT-UHFFFAOYSA-N 0.000 title claims description 8
- 230000003637 steroidlike Effects 0.000 title claims description 7
- 238000000034 method Methods 0.000 title claims description 6
- 150000002162 estranes Chemical class 0.000 title description 2
- PDRGHUMCVRDZLQ-UHFFFAOYSA-N d-equilenin Natural products OC1=CC=C2C(CCC3(C4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-UHFFFAOYSA-N 0.000 claims description 14
- 239000004480 active ingredient Substances 0.000 claims description 13
- PDRGHUMCVRDZLQ-WMZOPIPTSA-N equilenin Chemical compound OC1=CC=C2C(CC[C@]3([C@H]4CCC3=O)C)=C4C=CC2=C1 PDRGHUMCVRDZLQ-WMZOPIPTSA-N 0.000 claims description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 5
- YJBYRYVLFAUXBJ-HFTRVMKXSA-N [(9s,13s,14s)-13-methyl-17-oxo-9,11,12,14,15,16-hexahydro-6h-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 YJBYRYVLFAUXBJ-HFTRVMKXSA-N 0.000 claims description 4
- 239000000262 estrogen Substances 0.000 claims description 4
- YYHPEVZFVMVUNJ-UHFFFAOYSA-N n,n-diethylethanamine;sulfur trioxide Chemical compound O=S(=O)=O.CCN(CC)CC YYHPEVZFVMVUNJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical class CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- -1 TRIETHYLAMMONIUM SULFATES Chemical class 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- WKRLQDKEXYKHJB-UHFFFAOYSA-N Equilin Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3=CCC2=C1 WKRLQDKEXYKHJB-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 229920002261 Corn starch Polymers 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- WKRLQDKEXYKHJB-HFTRVMKXSA-N equilin Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 WKRLQDKEXYKHJB-HFTRVMKXSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007887 hard shell capsule Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000007499 fusion processing Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical class CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009164 estrogen replacement therapy Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 239000011872 intimate mixture Substances 0.000 description 1
- HCWCAKKEBCNQJP-UHFFFAOYSA-N magnesium orthosilicate Chemical compound [Mg+2].[Mg+2].[O-][Si]([O-])([O-])[O-] HCWCAKKEBCNQJP-UHFFFAOYSA-N 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229940100692 oral suspension Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82717669A | 1969-05-23 | 1969-05-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL32904A0 IL32904A0 (en) | 1969-11-30 |
| IL32904A true IL32904A (en) | 1972-12-29 |
Family
ID=25248500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL32904A IL32904A (en) | 1969-05-23 | 1969-08-27 | Steroidal triethylammonium sulfates of the estrane series and methods of preparing same |
Country Status (10)
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB662815A (en) * | 1948-07-15 | 1951-12-12 | Ayerst Mckenna & Harrison | Preparation of equilenin sulphate and its salts |
| US2666066A (en) * | 1951-09-28 | 1954-01-12 | Abbott Lab | Ethylenediamine salts of cyclopen-tanopolyhydrophenanthrene-3-monosulfates |
-
1969
- 1969-05-23 US US827176A patent/US3585222A/en not_active Expired - Lifetime
- 1969-08-26 GB GB42522/69A patent/GB1247448A/en not_active Expired
- 1969-08-27 IL IL32904A patent/IL32904A/en unknown
- 1969-09-02 IE IE1235/69A patent/IE33308B1/xx unknown
- 1969-09-03 NL NL6913437A patent/NL6913437A/xx unknown
- 1969-09-05 CH CH1350769A patent/CH540239A/de not_active IP Right Cessation
- 1969-09-09 FR FR6930631A patent/FR2044810A1/fr not_active Withdrawn
- 1969-09-09 DE DE19691945617 patent/DE1945617A1/de active Pending
- 1969-09-09 BE BE738633D patent/BE738633A/xx unknown
- 1969-09-18 BR BR212547/69A patent/BR6912547D0/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE738633A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-03-09 |
| DE1945617A1 (de) | 1971-02-04 |
| IE33308B1 (en) | 1974-05-15 |
| IL32904A0 (en) | 1969-11-30 |
| FR2044810A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1971-02-26 |
| US3585222A (en) | 1971-06-15 |
| NL6913437A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1970-11-25 |
| IE33308L (en) | 1970-11-23 |
| GB1247448A (en) | 1971-09-22 |
| CH540239A (de) | 1973-08-15 |
| BR6912547D0 (pt) | 1973-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3139709B2 (ja) | 調剤上適切なキャリアと構造（７α、１７α）‐１７‐ヒドロキシ‐７‐メチル‐１９‐ノル‐１７‐プレグン‐５（１０）‐エン‐２０‐イン‐３‐オンを有する化合物とを含む薬用組成物 | |
| EP3530271A1 (en) | Crystalline form ii of dextral oxiracetam, preparation method therefor and use thereof | |
| JPS6156135A (ja) | 精神分裂症治療方法およびそのための医薬 | |
| IE48133B1 (en) | A sold stable pharmaceutical composition based on 17 -ethynyl-1,3-dibenzoyloxy-7 -methyl-1,3,5(10)-oestratien-17 -ol | |
| US3144387A (en) | Anti-inflammatory compositions | |
| IL32904A (en) | Steroidal triethylammonium sulfates of the estrane series and methods of preparing same | |
| US4279914A (en) | Thrombocyte aggregation inhibiting composition and methods | |
| US3991186A (en) | Steryl-β-D-glucoside ester pharmaceutical compositions and method of use | |
| JPS5942656B2 (ja) | 抗脂血剤 | |
| JP2001525807A (ja) | プレグナン−３−オール−２０−オン | |
| US3127314A (en) | Method of reducing hyperlipemia by | |
| US3140233A (en) | Tasteless pharmaceutical composition and process | |
| JP3535207B2 (ja) | 抗ガン剤及びｇｒｐレセプター拮抗剤 | |
| JPS6119632B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US3144389A (en) | 2-hydroxy-2-phenyl-ethyl carbamate for muscle relaxation | |
| IL32902A (en) | Steroid sulfates of estrane series and methods of preparing the same | |
| US4464364A (en) | 6β,7β-Methylene-17α-pregn-4-ene-21,17-carbolactones, their preparation and use as medicinal agents | |
| EP0523013A2 (en) | Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases | |
| DE2036908C3 (de) | der Pregnanreihe, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen | |
| CH475240A (de) | Verfahren zur Herstellung von Indolderivaten | |
| US4005078A (en) | Dithioketal derivatives of 13-polycarbonalkylgon-4-en-3-ones | |
| DE2702058C2 (de) | Arzneimittel mit hypolipidämischer Wirkung und p-Aminobenzoesäurederivate | |
| JPS58188900A (ja) | １α，２α；６β，７β；１５β，１６β−トリメチレン−３−オキソ−１７α−プレグン−４−エン−２１，１７−カルボラクトン、その製法及び該合物を含有するアルドステロン「きつ」抗活性を有する医薬調剤 | |
| IL25392A (en) | 7alpha-methyl-5alpha-and 5beta-(19-nor)-androstanes | |
| DE1945619A1 (de) | OEstrogene,wasserloesliche Konjugate und ihre Herstellung |